XML 43 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Assets    
Cash and cash equivalents $ 2,117,000,000 $ 1,333,000,000
Receivables 152,000,000 142,000,000
Inventories:    
Leaf tobacco 874,000,000 940,000,000
Other raw materials 192,000,000 186,000,000
Work in process 696,000,000 647,000,000
Finished product 531,000,000 558,000,000
Inventory, net 2,293,000,000 2,331,000,000
Income taxes 116,000,000 167,000,000
Other current assets 146,000,000 326,000,000
Total current assets 4,824,000,000 4,299,000,000
Property, plant and equipment, at cost:    
Land and land improvements 353,000,000 309,000,000
Buildings and building equipment 1,461,000,000 1,442,000,000
Machinery and equipment 2,998,000,000 2,981,000,000
Construction in progress 262,000,000 218,000,000
Property, plant and equipment, at cost 5,074,000,000 4,950,000,000
Less accumulated depreciation 3,075,000,000 3,012,000,000
Property, plant and equipment, net 1,999,000,000 1,938,000,000
Goodwill 5,177,000,000 5,196,000,000
Other intangible assets, net 12,687,000,000 12,279,000,000
Investments in equity securities 23,581,000,000 30,496,000,000
Other assets 1,003,000,000 1,251,000,000
Total Assets 49,271,000,000 55,459,000,000
Liabilities    
Short-term borrowings 0 12,704,000,000
Current portion of long-term debt 1,000,000,000 1,144,000,000
Accounts payable 325,000,000 399,000,000
Accrued liabilities:    
Marketing 393,000,000 586,000,000
Settlement charges 3,346,000,000 3,454,000,000
Other 1,545,000,000 1,403,000,000
Dividends payable 1,565,000,000 1,503,000,000
Total current liabilities 8,174,000,000 21,193,000,000
Long-term debt 27,042,000,000 11,898,000,000
Deferred income taxes 5,083,000,000 4,993,000,000
Accrued pension costs 473,000,000 544,000,000
Accrued postretirement health care costs 1,797,000,000 1,749,000,000
Other liabilities 345,000,000 254,000,000
Total liabilities 42,914,000,000 40,631,000,000
Contingencies (Note 19)
Redeemable noncontrolling interest 38,000,000 39,000,000
Stockholders' Equity    
Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued) 935,000,000 935,000,000
Additional paid-in capital 5,970,000,000 5,961,000,000
Earnings reinvested in the business 36,539,000,000 43,962,000,000
Accumulated other comprehensive losses (2,864,000,000) (2,547,000,000)
Cost of repurchased stock (947,979,763 shares at December 31, 2019 and 931,903,722 shares at December 31, 2018) (34,358,000,000) (33,524,000,000)
Total stockholders’ equity attributable to Altria 6,222,000,000 14,787,000,000
Noncontrolling interests 97,000,000 2,000,000
Total stockholders’ equity 6,319,000,000 14,789,000,000
Total Liabilities and Stockholders’ Equity $ 49,271,000,000 $ 55,459,000,000